BIOMAT Database Logo BIOMAT Database Logo

Properties of TAN-67, a nonpeptidic delta-opioid receptor agonist, at cloned human delta- and mu-opioid receptors. 1995

R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
University of Arizona College of Medicine Department of Pharmacology, Tucson 85724, USA.

2-methyl-4a alpha-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12a alpha-octahydro-quinolino[2,3,30g]isoquinoline (TAN-67) is a nonpeptidic delta-opioid receptor agonist. This report describes its receptor binding affinity and agonist potency at human and mouse delta and mu-opioid receptors. The binding affinities of TAN-67 and the cyclic enkephalin analog, (D-Pen2, 4'-Cl-Phe4, D-Pen5]enkephalin (pCl-DPDPE) were measured by radioligand binding inhibition studies at mouse and human variants of the delta and mu-opioid receptor using [3H]Naltrindole and [3H]D-Phe-Cys-Tyr-D-Trp-Orn-Thr -Pen-Thr-NH2, respectively. TAN-67 showed high binding affinity (Ki = 0.647 nM) at the human delta-opioid receptor and high delta-opioid receptor binding selectivity ( > 1000-fold) relative to the human mu-opioid receptor. TAN-67 also showed high potency (EC50 = 1.72 nM) for the inhibition of forskolin-stimulated cAMP accumulation at human delta-opioid receptors expressed by intact Chinese hamster ovary cells but low potency (EC50 = 1520 nM) at human mu-opioid receptors expressed by intact B82 mouse fibroblast cells. The results show that TAN-67 has similar binding affinities, selectivity and potencies as pCl-DPDPE at human delta and mu-opioid receptors. These results combined with the nonpeptidic structure of TAN-67 suggest that this compound has therapeutic potential as a delta-opioid receptor agonist.

UI MeSH Term Description Entries
D011804 Quinolines
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005576 Colforsin Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant COLEUS FORSKOHLII. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. Coleonol,Forskolin,N,N-Dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl Ester HCl,NKH 477,NKH-477,NKH477
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
February 1997, The Journal of pharmacology and experimental therapeutics,
R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.
August 1999, European journal of pharmacology,
R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
Pentapeptides displaying mu opioid receptor agonist and delta opioid receptor partial agonist/antagonist properties.
December 2009, Journal of medicinal chemistry,
R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
Synthesis of optically active TAN-67, a highly selective delta opioid receptor agonist, and investigation of its pharmacological properties.
January 2001, Drug design and discovery,
R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
July 2001, Brain research bulletin,
R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
July 1999, European journal of pharmacology,
R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
November 1993, The Journal of pharmacology and experimental therapeutics,
R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
Supraspinal delta 1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice.
March 1997, European journal of pharmacology,
R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
June 1996, The Journal of pharmacology and experimental therapeutics,
R J Knapp, and R Landsman, and S Waite, and E Malatynska, and E Varga, and W Haq, and V J Hruby, and W R Roeske, and H Nagase, and H I Yamamura
Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice.
March 1995, European journal of pharmacology,
Copied contents to your clipboard!